Detalhe da pesquisa
1.
A framework for identification of actionable cancer genome dependencies in small cell lung cancer.
Proc Natl Acad Sci U S A
; 109(42): 17034-9, 2012 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23035247
2.
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC.
Cell Rep
; 31(4): 107568, 2020 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348765
3.
Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer.
Oncotarget
; 6(36): 38458-68, 2015 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26540572
4.
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.
Genome Biol
; 16: 7, 2015 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25650807
5.
Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer.
Cancer Res
; 74(10): 2816-24, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24675359
6.
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.
Cancer Discov
; 4(2): 246-57, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24302556
7.
CD74-NRG1 fusions in lung adenocarcinoma.
Cancer Discov
; 4(4): 415-22, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24469108
8.
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.
J Clin Invest
; 123(4): 1732-40, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23454747
9.
Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
Clin Cancer Res
; 18(24): 6658-67, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23082000
10.
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.
Sci Transl Med
; 2(62): 62ra93, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21160078